Uncertainty remains regarding the value of heart-rate-corrected QT interval (QTc) prolongation on electrocardiogram for predicting cardiovascular disease (CVD), particularly among Asian populations. The objective of the present analysis was to analyze the association of QTc prolongation with the development of CVD in a general Japanese population. During the follow-up period, 303 CVD events were observed. Among men, the age-adjusted incidence rates of CVD rose with prolonged QTc levels: 10.9, 12.1, 14.1 and 37.8 per 1000 person-years for subgroups defined by QTc levels of o400, 400-419, 420-439 and X440 ms, respectively (P¼0.0007 for trend). The risk of CVD in the highest group was 3.09-fold (95% confidence interval, 1.82-5.25) higher than that in the lowest group even after controlling for other confounding factors: age, hypertension, heart rate, electrocardiogram abnormalities, diabetes, impaired glucose tolerance, impaired fasting glycemia, body mass index, total and high-density lipoprotein cholesterols, alcohol intake, smoking habit and regular exercise. Similar associations were observed for the outcomes of stroke and coronary heart disease. Among women, in contrast, no clear associations were found between QTc levels and the risk of CVD events. In conclusion, prolonged QTc levels were associated with the development of CVD among general Japanese men. Measurement of QTc intervals is likely to provide additional information for the detection of individuals at high risk of future CVD events.
INTRODUCTION
Heart-rate-corrected QT interval (QTc) prolongation on the resting 12-lead electrocardiogram (ECG) has been associated with an increased risk for ventricular arrhythmia or sudden cardiac death. 1, 2 Recently, several epidemiological studies have also shown that QTc prolongation predicts the likelihood of cardiovascular disease (CVD), suggesting a possible link between QTc prolongation and atherosclerosis. [3] [4] [5] [6] [7] However, other epidemiological studies found no clear associations between QTc prolongation and the risk of CVD, [7] [8] [9] [10] and there is significant uncertainty surrounding the association between QTc prolongation and CVD. Furthermore, current knowledge of the effects of QTc prolongation on CVD was derived mainly from studies conducted in Western populations; it is unclear to what extent these findings apply to Asian populations. The objective of the present analysis was to analyze the longitudinal relationship between QTc prolongation and the future development of stroke and coronary heart disease in a long-term prospective study of a general Japanese population.
METHODS

Study population
Since 1961, we have been conducting a long-term prospective cohort study of CVD in the town of Hisayama, a suburb of Fukuoka City in Southern Japan. 11, 12 In 1988, a screening survey for this study was performed in the town. Detailed descriptions of this survey have been published previously. [13] [14] [15] [16] Briefly, a total of 2736 residents aged 40 years or older (80.7% of the total population of this age group) consented to participate in the examination. Among those, 102 subjects with a history of stroke or coronary heart disease were excluded from the present analysis based on the results of a questionnaire, face-to-face interviews, physical and neurological examinations, 12-lead ECG and, if necessary, other ancillary laboratory examinations. After further exclusion of 165 subjects who had had atrial fibrillation or ventricular conduction defects (QRS interval of 120 ms or longer), 22 subjects with high heart rates (X100 beats per minute) and 8 subjects whose ECG recordings were not available, we enrolled the remaining 2439 individuals in this study.
The ethics committee of Kyushu University approved this study, participants provided written informed consent, and the procedures followed were in accordance with national guidelines.
Follow-up survey
This population was followed up for 14 years, from December 1988 through November 2002, by repeated health examinations or by a daily monitoring system established by the study team and local physicians or members of the town's Health and Welfare Office. When a subject died, an autopsy was performed at the Department of Pathology of Kyushu University. During the follow-up period, 479 subjects died, of whom 362 (75.6%) underwent autopsy. Morphologic examinations by autopsy or brain imaging were performed on all stroke patients. 17 Only one subject was lost to follow-up.
Measurements of QTc
Standard, resting 12-lead ECG was recorded on an FCP-270 device (Fukuda Denshi, Tokyo, Japan) in the supine position on the morning of the screening surveys conducted in 1988. Heart rate (beats per minute) and QT interval duration (ms) were determined using ECG analysis software (PI-01, Fukuda Denshi) as described previously. 18 The program calculated the mean values of QT interval duration from the beginning of QRS to the end of the T wave in 12-lead ECG. The average QT interval duration was then corrected for heart rate by calculating QTc according to Bazett's equation (QTc¼QT interval duration/ (60/heart rate) 1/2 ). 19 Groups of participants defined by four QTc ranges (o400, 400-419, 420-439 and X440 ms) were used for the analysis.
Risk factors
A self-administered questionnaire covering medical history, alcohol consumption, smoking habit and regular exercise was completed in advance by each participant and was verified by trained interviewers at the baseline screening examination. Alcohol consumption and smoking habit were classified as either habitual or not. Subjects engaging in sports or other forms of exertion X3 times a week during their leisure time were assigned to the regular exercise group. Blood pressure was measured three times with the subject in a recumbent position, after having rested for at least 5 min before the first measurement and again for at least 5 min between measurements, by means of a standard sphygmomanometer with a standard cuff. 12, 20 Korotkoff phase 5 was taken as the diastolic BP unless the sounds persisted at 0, in which case Korotkoff phase 4 was recorded. The mean of the three measurements was used in the present analysis. Hypertension was defined as blood pressure of X140/ 90 mm Hg or current use of antihypertensive agents. Body height and weight were measured in light clothing without shoes, and body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared. Obesity was defined as BMI X25.0 kg m -2 . ECG abnormalities were defined as left ventricular hypertrophy (Minnesota code: 3-1) and/or ST depression (Minnesota codes: 4-1, 4-2 or 4-3). To determine serum lipid levels, blood samples were collected from an antecubital vein after an overnight fast. Total cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides were determined enzymatically. Dyslipidemia was defined as total cholesterol X5.68 mmol l -1 , HDL-cholesterol p1.03 mmol l -1 or triglycerides X1.69 mmol l -1 . Non-HDL cholesterol was defined as total cholesterol excluding HDL cholesterol. At the baseline examination, we also performed the 75 g glucose tolerance test. Plasma glucose levels were determined by the glucose-oxidase method. Glucose tolerance status was also defined by the 1998 World Health Organization criteria; 21 namely, for impaired fasting glycemia, FPG 6.1-6.9 mmol l -1 and 2-h PG o7.8 mmol l -1 ; for impaired glucose tolerance, FPG o7.0 mmol l -1 and 2-h PG 7.8-11.0 mmol l -1 ; and for diabetes mellitus, FPG X7.0 mmol l -1 and/or 2-h PG X11.1 mmol l -1 .
Definition of cardiovascular events
The outcomes of the present analysis were stroke, coronary heart disease and total CVD events (stroke and coronary heart disease). Stroke was defined as a sudden onset of nonconvulsive and focal neurological deficit persisting for more than 24 h. Rare causes of cerebrovascular disease, such as collagen disease, hematologic disorder, trauma, chronic subdural hematoma or Moyamoya disease, were not considered among the stroke cases. The diagnosis and classification of stroke were based on clinical information, ancillary laboratory examinations (that is, neuroimaging, cerebral angiography, echocardiography or carotid duplex imaging) and autopsy findings.
The criteria for a diagnosis of coronary heart disease included first-ever fatal or non-fatal myocardial infarction, sudden cardiac death within 1 h of the onset of acute illness, or coronary artery disease followed by coronary artery bypass surgery or angioplasty. Myocardial infarction was diagnosed when a subject met at least two of following criteria: (1) typical symptoms, including prolonged severe anterior chest pain; (2) abnormal cardiac enzymes more than twice the upper limit of the normal range; (3) evolving diagnostic ECG changes; or (4) morphologic changes of the heart, including local asynergy of cardiac wall motion on echocardiography, persistent perfusion defect on cardiac scintigraphy or myocardial necrosis or scars 41 cm long accompanied by coronary atherosclerosis at autopsy. Sudden cardiac death was defined as natural death attributable to cardiac causes, heralded by an abrupt loss of consciousness, within 1 h after onset of acute symptoms.
Statistical analysis
The incidence rates were calculated using the person-year method and adjusted for age by the direct method using 10-year age groupings. Differences in incidence rates between subgroups defined by QTc levels were tested using the Cox proportional hazards model including age. The multivariate-adjusted hazard ratio (HR) and 95% confidence interval (CI) were also estimated using the Cox proportional hazards model. A P-value of o0.05 was considered statistically significant in all analyses. The SAS program (SAS Institute, Cary, NC, USA) was used to perform all statistical analyses.
RESULTS
Mean QTc levels were 403 ms for men and 417 ms for women. The baseline characteristics according to QTc prolongation (4440 ms) are shown separately for men and women in Table 1 . In both sexes, the subjects with QTc prolongation were older, were more likely to have had hypertension, ECG abnormalities, dyslipidemia and smoking habit, and had higher systolic blood pressure, heart rate, plasma fasting glucose and serum triglycerides than those without QTc prolongation.
During the 14-year follow-up period, 145 CVD events (stroke, 85 events; coronary heart disease, 73 events) were observed in men and 158 CVD events (stroke, 121 events; coronary heart disease, 51 events) in women. Table 2 shows the age-adjusted incidence rates and multivariate-adjusted HRs for the development of stroke, coronary heart disease and total CVD according to QTc levels among men. The incidence rates of stroke rose progressively with increasing QTc levels, and the highest risk of stroke was observed in the subgroup with QTc levels of X440 ms. These relationships remained significant even after controlling for age, hypertension, heart rate, ECG abnormalities, diabetes, impaired glucose tolerance, impaired fasting glycemia, BMI, total and HDL cholesterol, alcohol consumption, smoking habit and regular exercise (P¼0.02 for trend). Comparable associations were also observed for coronary heart disease (P¼0.001 for trend) and total CVD (P¼0.0004 for trend). When non-HDL cholesterol was included in the multivariate model as a covariate instead of total cholesterol, similar results were obtained (P trend¼0.02 for stroke, 0.001 for coronary heart disease and 0.0004 for total CVD).
In contrast to men, women showed no clear associations between QTc levels and incidence rates of total and cause-specific CVD (Table 3 , P trend¼0.23 for stroke, 0.76 for coronary heart disease and 0.58 for total CVD). These associations remained insignificant even after adding non-HDL cholesterol into the multivariate model instead of total cholesterol (P trend40.2 for all outcomes). Multivariate-adjusted HRs of QT interval prolongation declined as QTc X450 ms and X460 ms compared with the reference group with QTc o 400 ms were 1.56 (95% CI, 0.76-3.21) and 1.55 (95% CI, 0.68-3.57) for stroke, 1.00 (95% CI, 0.32-3.17) and 1.17 (95% CI, 0.30-4.58) for coronary heart disease, and 1.21 (95% CI, 0.65-2.25) and 1.37 (95% CI, 0.67-2.78) for total CVD. Multivariate-adjusted HRs per 10-ms increase in QTc interval were 1.05 (95% CI, 0.98-1.13) for stroke, 1.03 (95% CI, 0.91-1.17) for coronary heart disease and 1.03 (95% CI, 0.96-1.10) for total CVD among women.
To examine the combined effect of prolonged QTc and other cardiovascular risk factors on CVD incidence, we estimated the ageadjusted HRs of CVD among four groups of male subjects according to the presence or absence of QTc prolongation (4440 ms) and each of the other risk factors (Table 4) . Compared with the reference group without QTc prolongation or hypertension, the risk of developing CVD was significantly higher for the groups with either QTc Abbreviations: QTc, heart-rate-corrected QT interval; 95% CI, 95% confidence interval. a Hazard ratios and P-values were adjusted for age, hypertension, heart rate, electrocardiographic abnormalities, diabetes, impaired glucose tolerance, impaired fasting glycemia, body mass index, total and high-density lipoprotein cholesterol, alcohol consumption, smoking habit and regular exercise. Table 3 Age-adjusted incidence rate and multivariate-adjusted hazard ratio for development of stroke, coronary heart disease, and total cardiovascular disease according to heart-rate-corrected QT interval among women Abbreviations: QTc, heart-rate-corrected QT interval; 95% CI, 95% confidence interval. *Hazard ratios and P-values were adjusted for age, hypertension, heart rate, electrocardiographic abnormalities, diabetes, impaired glucose tolerance, impaired fasting glycemia, body mass index, total and high-density lipoprotein cholesterol, alcohol consumption, smoking habit, and regular exercise. prolongation or hypertension, and the highest risk was observed for the group with both QTc prolongation and hypertension. Similar associations were observed for combinations of QTc prolongation and every other risk factor (diabetes, obesity, dyslipidemia or current smoking). There were no significant interactions between QTc prolongation and these cardiovascular risk factors (all P40.1 for interaction). The findings obtained from these analyses were substantially unchanged even after controlling for other risk factors in the multivariate analyses. Age-adjusted HRs for the development of total CVD according to the presence or absence of QTc prolongation (4440 ms) and number of risk factors (0-1 vs. X2) among men are also shown in Table 5 . There were no significant interactions between QTc prolongation and the number of risk factors (P¼0.89 for interaction).
DISCUSSION
The present prospective analysis of a community-dwelling Japanese population clearly shows that QTc prolongation on ECG is an independent predictor of stroke, coronary heart disease and total CVD events among men. These associations remained strong even after controlling for age, hypertension, heart rate, ECG abnormalities, diabetes, impaired glucose tolerance, impaired fasting glycemia, BMI, total and HDL cholesterol, alcohol consumption, smoking habit and regular exercise. Furthermore, the effects of QTc were comparable for patients with or without other cardiovascular risk factors such as hypertension, diabetes, obesity, dyslipidemia or current smoking. However, similar associations were not observed for women.
To the best of our knowledge, only two hospital-based prospective studies have reported an association between QT interval prolongation and the risk of stroke. 5, 7 QT interval prolongation (QTc X470 ms) was associated with 2.2-fold higher incidence rates of stroke among 471 Brazilian subjects with type 2 diabetes, 5 whereas no clear associations between QT interval prolongation (QTc X440 ms for men and QTc X450 ms for women) and the development of stroke were found among 2110 Italian subjects with essential hypertension. 7 This study is the first to examine this issue in a general population and clearly shows that QT interval prolongation can predict the incidence of stroke among Japanese men.
A few large-scale observational studies have investigated the association between QT interval prolongation and the future risk of coronary heart disease. 3, 4, 6 The Atherosclerosis Risk in Communities study reported that QT interval prolongation (QTc X440 ms for men and QTc X454 ms for women) was associated with 1.5-to 5.0-fold increased risk of incident coronary heart disease among general populations of white Americans or African Americans. 3 Robbins et al. 4 reported that elderly subjects in the United States with QTc intervals 4450 ms had higher coronary heart disease mortality than those with QTc intervals o410 ms. The Zutphen study showed that Dutch men with prolonged QTc (X440 ms) had 3.3-to 4.3-fold higher risk of death from coronary heart disease. 6 An Adult Health Study of the Radiation Effects Research Foundation showed that elderly Japanese with prolonged QTc (4 440 ms) had a 2.49-fold higher risk of coronary death compared with those with QTc intervals p420 ms. 22 The present analysis from the Hisayama study confirms the results of previous cohort studies and provides more detailed information regarding the effects of QTc prolongation on the risk of future coronary events in Japanese men.
The mechanism underlying the association between QT interval prolongation and CVD has not been clearly defined, but the QT interval has been shown to be related to ventricular hypertrophy. 23 QT interval has also been shown to be associated with subclinical arterial disease. [24] [25] [26] Thus, QT interval prolongation, as a marker of ventricular hypertrophy or subclinical arterial disease, may predict future CVD events.
Another important finding from the present analysis is the lack of clear associations between QTc prolongation and CVD among women. This finding was consistent with previous observational studies. Schouten et al. have shown that QTc prolongation (X440 ms) was associated with 1.8-fold higher mortality rates from CVD among healthy Dutch men, but not among women. The reason for this finding has not been clearly resolved, but it has been suggested that sex hormones attenuate the association between QT interval prolongation and CVD. Estrogen has been reported to prolong the QT interval through downregulation of HERG-encoded potassium channel expression. 27 At the same time, endogenous estrogen has been shown to protect against the development of atherosclerosis. 18, 27, 28 Such conflicting effects of sex hormones might weaken the association of QT interval with CVD among women. Another possible reason for the sex difference in the risks of CVD might stem from differences in the atherosclerotic process between men and women. Generally, it is considered that atherosclerosis progresses at a faster rate in men than in women. Thus, it may be easier to detect the association between QT interval prolongation and CVD in men.
Several limitations of our study should be discussed. First, our study lacks information on medication use, which could affect the QT interval duration. It is known that several medications, including antiarrhythmic medications, antibiotics, antipsychotic agents or antihistamines can alter QT interval duration. However, these medications were rarely used in Japan in 1988, when the ECGs in our study were performed. This suggests that such a bias did not invalidate the present findings. Second, we have no information on subjects with congenital long-QT syndrome. However, the prevalence of congenital long-QT syndrome has been reported to be o0.1%. 29 Thus, the influence of congenital long-QT syndrome would seem to be negligible. Third, our findings are based on a 1-day measurement of clinical findings such as ECG, blood pressure levels and blood tests, which may not accurately reflect the status of the study participants. Errors in measuring QTc interval, blood pressure levels or blood test results could have weakened the relationships in the present analysis. Abbreviations: QTc, heart-rate-corrected QT interval; QTc prolongation, QTc X440 ms; 95% CI, 95% confidence interval. a Hypertension, diabetes, obesity, dyslipidemia and current smoking.
However, this source of variability could not account for the relationship observed in this study, because a random misclassification of such a nature would tend to underestimate the study findings and bias the results toward the null hypothesis. Thus, the true association may be stronger than that observed in our study.
In conclusion, our study found that QTc prolongation was an independent predictor of stroke and coronary heart disease in a general population of Japanese male subjects. QTc measurement is a low-cost and noninvasive test to detect high-risk males who should receive special attention. Approaches for the prevention of high-risk CVD using QTc measurement are likely to provide additional protection against the burden of CVD among Japanese male subjects.
